1-6 of 6
Raffaella Meazza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors

Free
Loredana Cifaldi, Paolo Romania, Michela Falco, Silvia Lorenzi, Raffaella Meazza, Stefania Petrini, Marco Andreani, Daniela Pende, Franco Locatelli, Doriana Fruci
Journal: Cancer Research
Cancer Res (2015) 75 (5): 824–834.
https://doi.org/10.1158/0008-5472.CAN-14-1643
Published: 01 March 2015
View articletitled, ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors
Open the PDF for ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors in another window
Includes: Supplementary data
Journal Articles

Regulatory T cell depletion and an IL-21-secreting cellular vaccine act synergistically in syngeneic micrometastases immunotherapy

Free
Ombretta Rosso, Alberto Comes, Anna Maria Orengo, Emma Di Carlo, Raffaella Meazza, Patrizia Nanni, Mario P. Colombo, Silvano Ferrini
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 567.
Published: 01 May 2005
View articletitled, Regulatory T cell depletion and an IL-21-secreting cellular vaccine act synergistically in syngeneic micrometastases immunotherapy
Journal Articles

Inhibition of Mammary Carcinoma Development in HER-2/neu Transgenic Mice through Induction of Autoimmunity by Xenogeneic DNA Vaccination

Free
Serenella M. Pupa, Manuela Iezzi, Emma Di Carlo, AnnaMaria Invernizzi, Federica Cavallo, Raffaella Meazza, Alberto Comes, Silvano Ferrini, Piero Musiani, Sylvie Ménard
Journal: Cancer Research
Cancer Res (2005) 65 (3): 1071–1078.
https://doi.org/10.1158/0008-5472.1071.65.3
Published: 10 February 2005
View articletitled, Inhibition of Mammary Carcinoma Development in HER-2/neu Transgenic Mice through Induction of Autoimmunity by Xenogeneic DNA Vaccination
Open the PDF for Inhibition of Mammary Carcinoma Development in HER-2/neu Transgenic Mice through Induction of Autoimmunity by Xenogeneic DNA Vaccination in another window
Journal Articles

Immunoprevention of HER-2/ neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Free
Carla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, Annalisa Astolfi, Stefania Croci, Alberto Comes, Silvano Ferrini, Raffaella Meazza, Manuela Iezzi, Emma Di Carlo, Piero Musiani, Federica Cavallo, Patrizia Nanni, Pier-Luigi Lollini
Journal: Cancer Research
Cancer Res (2004) 64 (11): 4001–4009.
https://doi.org/10.1158/0008-5472.CAN-03-2984
Published: 01 June 2004
View articletitled, Immunoprevention of HER-2/ neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine
Open the PDF for Immunoprevention of HER-2/ neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine in another window
Includes: Supplementary data
Journal Articles

Murine mammary adenocarcinoma cells genetically modified with IL-21 induce a protective immune response involving CTLs and IFN-gamma

Free
Alberto Comes, Emma Di Carlo, Anna Maria Orengo, Ombretta Rosso, Raffaella Meazza, Piero Musiani, Mario Paolo Colombo, Silvano Ferrini
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1119–1120.
Published: 01 April 2004
View articletitled, Murine mammary adenocarcinoma cells genetically modified with IL-21 induce a protective immune response involving CTLs and IFN-gamma
Journal Articles

Gene expression profiles reveal block of progression to mammary carcinoma in HER-2/neu transgenic mice receiving immunopreventive treatment

Free
Annalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Stefania Croci, Alberto Comes, Raffaella Meazza, Silvano Ferrini, Emma Di Carlo, Manuela Iezzi, Piero Musiani, Patrizia Nanni, Pier-Luigi Lollini
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1263.
Published: 01 April 2004
View articletitled, Gene expression profiles reveal block of progression to mammary carcinoma in HER-2/neu transgenic mice receiving immunopreventive treatment